China's State FDA To Select Provinces For Drug Safety Pilot Programs
This article was originally published in PharmAsia News
Executive Summary
China's State FDA recently issued guidance to request designated regions to pilot a drug safety accountability system, in a bid to enhance the country's drug safety work mechanism